Adicet Bio, Inc.
ACET· Nasdaq
Released Aug 13, 2024, before the open
10-Q filed Aug 13, 2024, 44 days after period end · 0000950170-24-095745
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Net Income | -$29.90M | -$32.40M | -$22.54M | -$10.85M |
| EPS Diluted | -$0.33 | -$0.75 | -$0.56 | -$0.34 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Adicet Bio, Inc. · CIK 1720580 · Engraved from SEC EDGAR